Ellagic acid protects dopamine neurons from rotenone‐induced neurotoxicity via activation of Nrf2 signalling
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ellagic acid protects dopamine neurons from rotenone‐induced neurotoxicity via activation of Nrf2 signalling
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 24, Issue 16, Pages 9446-9456
Publisher
Wiley
Online
2020-07-13
DOI
10.1111/jcmm.15616
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroprotective Role of Astroglia in Parkinson Disease by Reducing Oxidative Stress Through Dopamine-Induced Activation of Pentose-Phosphate Pathway
- (2018) Kyoko Mashima et al. ASN Neuro
- Astrocytes as targets for drug discovery
- (2018) Kirill Gorshkov et al. DRUG DISCOVERY TODAY
- Nrf2 protects against acute lung injury and inflammation by modulating TLR4 and Akt signaling
- (2018) Jia Yan et al. FREE RADICAL BIOLOGY AND MEDICINE
- The possible neuroprotective effect of ellagic acid on sodium arsenate-induced neurotoxicity in rats
- (2018) Mehdi Goudarzi et al. LIFE SCIENCES
- Resveratrol attenuates testicular apoptosis in type 1 diabetic mice: Role of Akt-mediated Nrf2 activation and p62-dependent Keap1 degradation
- (2018) Yuguang Zhao et al. Redox Biology
- Astrocytes, Microglia, and Parkinson's Disease
- (2018) Eun-Hye Joe et al. Experimental Neurobiology
- Circadian control of BDNF-mediated Nrf2 activation in astrocytes protects dopaminergic neurons from ferroptosis
- (2018) Tetsuro Ishii et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones
- (2018) Matheus de Freitas Silva et al. MOLECULES
- Ellagic acid: Insights into its neuroprotective and cognitive enhancement effects in sporadic Alzheimer's disease
- (2018) Abhishek B. Jha et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Matrix Metalloproteinase Response of Dendritic Cell, Gingival Epithelial Keratinocyte, and T-Cell Transwell Co-Cultures Treated with Porphyromonas gingivalis Hemagglutinin-B
- (2018) Amber Bates et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Polydatin Prevents Lipopolysaccharide (LPS)-Induced Parkinson's Disease via Regulation of the AKT/GSK3β-Nrf2/NF-κB Signaling Axis
- (2018) Bingxu Huang et al. Frontiers in Immunology
- Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders
- (2017) Beihui Liu et al. GLIA
- Melatonin successfully rescues hippocampal bioenergetics and improves cognitive function following drug intoxication by promoting Nrf2-ARE signaling activity
- (2017) Li-You Chen et al. JOURNAL OF PINEAL RESEARCH
- The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
- (2017) Helena Xicoy et al. Molecular Neurodegeneration
- Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model
- (2017) Pia Rivetti di Val Cervo et al. NATURE BIOTECHNOLOGY
- Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
- (2017) Panchanan Maiti et al. Translational Neurodegeneration
- Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease
- (2016) Isabel Lastres-Becker et al. ANTIOXIDANTS & REDOX SIGNALING
- Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician’s Expectation Be Matched by the Reality?
- (2016) Christine A. Houghton et al. Oxidative Medicine and Cellular Longevity
- Microglial regulation of immunological and neuroprotective functions of astroglia
- (2014) Shih-Heng Chen et al. GLIA
- Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
- (2013) Stacey Ruiz et al. KIDNEY INTERNATIONAL
- Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
- (2013) Amaal AlDakheel et al. Neurotherapeutics
- Astrocyte-Specific Overexpression of Nrf2 Delays Motor Pathology and Synuclein Aggregation throughout the CNS in the Alpha-Synuclein Mutant (A53T) Mouse Model
- (2012) L. Gan et al. JOURNAL OF NEUROSCIENCE
- Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis
- (2011) Arie Neymotin et al. FREE RADICAL BIOLOGY AND MEDICINE
- Parkinson’s disease: oxidative stress and therapeutic approaches
- (2010) Sankar Surendran et al. NEUROLOGICAL SCIENCES
- Repeated transient sulforaphane stimulation in astrocytes leads to prolonged Nrf2-mediated gene expression and protection from superoxide-induced damage
- (2010) Petra Bergström et al. NEUROPHARMACOLOGY
- Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte
- (2009) Pei-Chun Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started